Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant (Q80818732)

From Wikidata

Jump to navigation Jump to search

scientific article published on 02 August 2007

Language	Label	Description	Also known as
English	Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant	scientific article published on 02 August 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Mycobacterium tuberculosis

1 reference

based on heuristic

inferred from title

immunologic adjuvant

1 reference

based on heuristic

inferred from title

author name string

Chaitra MG

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Nayak R

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shaila MS

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

2 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

7168-7176

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

The global tuberculosis situation and the new control strategy of the World Health Organization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Tuberculosis: commentary on a reemergent killer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

The death and resurrection of tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

The PE-PGRS glycine-rich proteins of Mycobacterium tuberculosis: a new family of fibronectin-binding proteins?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Comparative immune response to PE and PE_PGRS antigens of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Analysis of the proteome of Mycobacterium tuberculosis in silico

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Inhibitory effect of trehalose dimycolate (TDM) and its stereoisometric derivatives, trehalose dicorynomycolates (TDCMs), with low toxicity on lung metastasis of tumour cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

On-column refolding of recombinant human interleukin-4 from inclusion bodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

The immunogenicity of Mycobacterium paratuberculosis 85B antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Identification of nitric oxide synthase as a protective locus against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Prime-boost strategies for malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

A single vaccination with protein-microspheres elicits a strong CD8 T-cell-mediated immune response against Mycobacterium tuberculosis antigen Mtb8.4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.07.026

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.07.026

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17709160%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80818732&oldid=2215612014"